CIK 0001385818
- Non-accelerated filer
- Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470883144
- Phone
- +1 720-437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 3 Insider Initial Statement of Ownership
- 4 Grant or award VP of Commercial Operations acquired 140,000 shares (grant or award)
- 4 Grant or award Director acquired 65,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 165,000 shares (grant or award)
- 4 Grant or award Director acquired 65,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 190,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 165,000 shares (grant or award)
- 4 Open-market buy Director bought 5,000,000 shares at $0.40 ($2,000,000)
- 4 Open-market buy Chief Executive Officer bought 250,000 shares at $0.40 ($100,000)
- 4 Open-market buy Chief Operating Officer bought 250,000 shares at $0.40 ($100,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 153,846 shares at $0.65 ($100,000)
- 4 Open-market buy Chief Operating Officer bought 153,846 shares at $0.65 ($100,000)
- 4 Other disposition 10% owner disposed of 10,399,661 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 10 · 187 filings